Sponsor
AvenCell Europe GmbH
Tatzberg 47, Johannstadt-Nord, 01307 Dresden, Germany
About the sponsor
AvenCell Europe GmbH focuses its clinical research on acute myeloid leukemia and related CD123-positive hematologic malignancies, with an emphasis on diseases driven by abnormal blood cell growth.
- Acute myeloid leukemia
- CD123-positive hematologic malignancies
- Blood cancer treatment
The sponsor’s trial portfolio is centered on patients with hematologic cancer profiles that express CD123, reflecting a targeted interest in malignancies of the bone marrow and blood.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.